Picture of MindMaze Therapeutics Holding SA logo

MMTX MindMaze Therapeutics Holding SA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Swiss stocks - Factors to watch on January 27

ZURICH/BERLIN, Jan 27 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Thursday:
    
    UBS  UBSG.S 
    Swiss bank UBS has agreed to buy U.S.-focused automated
wealth management provider Wealthfront, which has more than $27
billion in assets under management, in an all-cash deal the two
companies said was worth $1.4 billion.  urn:newsml:reuters.com:*:nZ8N2RV007
    
    NESTLE  NESN.S 
    Nestle will start paying cocoa farmers cash if they send
their children to school rather than out to tend crops as part
of a push to purchase all of its cocoa through a fully
traceable, directly sourced supply chain by 2025  NESN.S 
        
    SGS SA  SGSN.S  
    The testing and inspection group forecast mid-single-digit
organic growth in 2022 and higher underlying operating income
after it rebounded in 2021 from the pandemic-triggered downturn
 SGSN.S 
    
    COMPANY STATEMENTS
    * Liechtensteinische Landesbank AG  LLBN.S : LLB intends to
extend a public purchase offer to Bank Linth  LINN.S 
shareholders in order to increase LLB's equity share of Bank
Linth from current level of 74.9% to 100% 
    * Givaudan  GIVN.S  says it acquired a 48% stake in
Nanovetores Group from the Criatec Fund, a Brazilian investment
fund  GIVN.S 
    * Bellevue Group AG  BBN.S : anticipates significantly
higher net profit of CHF 43 mn (+93%) - ordinary dividend to be
increased by 80% to CHF 2.70  BBN.S 
    * Bucher Industries  BUCN.S  reports FY 2021 order intake
exceeded high 2019 level by nearly a third.  BUCN.S 
    * Achiko AG  ACHIN.S : appoints David Hodge to role of head
of corporate development in Switzerland  ACHIN.S 
    * Relief Therapeutics Holding SA  RLFB.S : Relief reports
that its U.S. collaboration partner has announced receipt of
initial report of patient safety and survival from right to try
use of aviptadil during Omicron surge  RLFB.S 
    
    ANALYST VIEWS
    COMPAGNIE FINANCIERE RICHEMONT SA  CFR.S : RBC RAISES TARGET
PRICE TO CHF 173 FROM CHF 157
    ABB LTD  ABBN.S : JEFFERIES RAISES TARGET PRICE TO CHF 30
FROM CHF 29
    LONZA GROUP AG  LONN.S : BERENBERG CUTS TARGET PRICE TO CHF
780 FROM CHF 870
    
    ECONOMY
    Swiss December trade balance due at 0700 GMT

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on MindMaze Therapeutics Holding SA

See all news